Abstract:Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Growing evidence from clinical investigations has shown that increased serum levels of YKL-40 are correlated with short survival and metastasis in a broad type of human cancers. These data suggest that YKL-40 in the blood may present a powerful tool for cancer diagnosis and prognosis. However, pathological activity of YKL-40 in cancer development is poorly understood. Here, we explored a functional role for YKL-40 in vasculature development of human cancer. In a survey of twenty cases of breast ductal carcinoma in situ (DCIS) and thirty-eight cases of infiltrating ductal carcinoma (IDC), we found that expression levels of YKL-40 in specimens from DCIS were barely detectable, but different levels of YKL-40 were present in IDC. Nine out of thirty-eight IDC cases showed high levels of YKL-40 and nine cases displayed medium levels of YKL-40, whereas the rest twenty cases were low or negative. Interestingly, in an analysis of vasculature formation in these IDC samples, we found that different blood vessel densities significantly correlated with different degrees of YKL-40 expression. To test this possible angiogenic activity of YKL-40 in tumor development, we utilized angiogenic xenograft models by subcutaneous injection of SCID/Beige mice with a brain tumor line U87 cells which express strong endogenous YKL-40 and U87 cells with siRNA knockdown of YKL-40. siRNA knockdown of YKL-40 notably suppressed tumor angiogenesis and tumor development relative to high levels of YKL-40 expressed in control U87 cells. Further, to dissect cellular and molecular mechanisms underlying YKL-40-induced tumor angiogenesis, we treated human microvascular endothelial cells with YKL-40 and found that YKL-40 was capable of binding to heparan sulfate on ectodomain of membrane receptor syndecan-1 (S1). The activated S1 prompted its interaction with adjacent receptor integrin αvβ3, leading to activation of intracellular cascades including phosphorylation of focal adhesion kinase and MAP kinase. A series of individual signaling inhibitors blocked YKL-40-induced angiogenesis in vitro. Collectively, these data strongly suggest that YKL-40 expressed in cancer activates vascular endothelial cell angiogenesis to promote tumor development. These findings may hold promise for developing novel therapeutic agents targeting YKL-40, a cancer biomarker that is overexpressed in a wide range of human cancers. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1732.

The Effects of YKL-40 on Angiogenic Potential of HUVECs Are Partly Mediated by Syndecan-4.

YKL-40, a Secreted Glycoprotein, Promotes Tumor Angiogenesis

Syndecan-4 Overexpression Enhances Human Umbilical Vein Endothelial Cells Proliferation

Syndecan-4 Regulates the Bfgf-Induced Chemotactic Migration of Endothelial Cells

Effects of a Small Interfering RNA Targeting YKL-40 Gene on the Proliferation and Invasion of Endometrial Cancer HEC-1A Cells

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis

Tumor-derived Mural-Like Cells Coordinate with Endothelial Cells: Role of YKL-40 in Mural Cell-Mediated Angiogenesis.

Knockdown of YKL‐40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer

The Effect of the Knock-Down of the Ezrin Gene by Sirna on Proliferation of HUVECs

Influence of YKL-40 gene RNA interference on the biological behaviors of endometrial cancer HEC-1A cells.

[Inhibition of Proliferation and Migration of Human Umbilical Vein Endothelial Cells by Knockdown of Cylindromatosis (CYLD) Gene].

Influence of Specific Blocking of the Delta-Like Ligand 4/notch Signal Transduction Pathway on the Biological Behavior of Human Umbilical Vein Endothelial Cells

Inhibitory Effect of Sanguinarine on TGF-β1-induced Endothelial-Mesenchymal Transition of HUVEC

The Influence of Ys-1 on the Dll4-Notch1 Signaling Pathway

Impact of the transfer of sFlt-1 gene fragments on the ERK1/2 pathway of VEGF in vitro.

Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma.

Effects of CXCL4 on human dermal microvascular endothelial cells and secretion of vasomotion factors

Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1

A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.

Elevated Expression Of Ykl-40, A Cancer Biomarker, Is Associated With Tumor Angiogenesis

Expression of Soluble Vascular Endothelial Growth Factor Receptor-2 and Its Effect on Proliferation of Vascular Endothelial Cells